Internal Medicine · Philadelphia, PA
NPI
1093072944
Since 2012
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
1015 Chestnut St Ste 1321
Philadelphia, PA, 19107
Phone (215) 955-4730
Groups this clinician bills Medicare through
Medicare paid, 2024
$34K
373 services
Medicare patients, 2024
210
Average age 71
Drug cost, 2024
$1.4M
460 prescriptions
Company payments, 2025
$2,321
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ruben W Rhoades was code 99214 (office e&m - established), 84 times for 66 patients. In total Ruben W Rhoades billed 373 services in 15 codes, and Medicare paid $34K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-06-20.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 84 | 66 | $70.15 | $5,892 |
| 99233 Hospital E&M - Subsequent | Facility | 66 | 29 | $94.96 | $6,267 |
| 99215 Office E&M - Established | Facility | 44 | 37 | $114.09 | $5,020 |
| 99232 Hospital E&M - Subsequent | Facility | 36 | 24 | $60.66 | $2,184 |
| 99222 Hospital E&M - Initial | Facility | 26 | 26 | $100.49 | $2,613 |
| 99214 Office E&M - Established | Office | 26 | 20 | $96.67 | $2,513 |
| 99223 Hospital E&M - Initial | Facility | 25 | 24 | $133.96 | $3,349 |
| 99204 Office E&M - New | Facility | 25 | 25 | $94.17 | $2,354 |
By year: 2022 $43K for 407 services; 2023 $44K for 452 services; 2024 $34K for 373 services.
Medicare prescription drug claims, 2024
In 2024, the drug Ruben W Rhoades prescribed most often to Medicare patients was Hydroxyurea, with 83 prescriptions and refills. In total Ruben W Rhoades wrote 460 Medicare prescriptions that cost $1.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydroxyurea Generic | 83 | 202 | 20 | $2,620 |
| Eliquis Apixaban | 78 | 138 | 16 | $80K |
| Warfarin Sodium Generic | 40 | 118 | Under 11 | $379 |
| Tranexamic Acid Generic | 37 | 37 | 14 | $1,229 |
| Jakafi Ruxolitinib Phosphate | 22 | 22 | Under 11 | $462K |
| Promacta Eltrombopag Olamine | 19 | 21 | Under 11 | $221K |
| Sandostatin Lar Depot Octreotide Acetate,mi-Spheres | 17 | 24 | Under 11 | $114K |
| Retacrit Epoetin Alfa-Epbx | 17 | 19 | Under 11 | $23K |
| Morphine Sulfate Er Morphine Sulfate | 16 | 16 | Under 11 | $545 |
| Prednisone Generic | 14 | 14 | Under 11 | $46.7 |
| Enoxaparin Sodium Generic | 12 | 16 | Under 11 | $6,400 |
| Givlaari Givosiran Sodium | 12 | 12 | Under 11 | $511K |
| Cyclosporine Modified Cyclosporine, Modified | 11 | 11 | Under 11 | $667 |
| Xarelto Rivaroxaban | 11 | 19 | Under 11 | $15K |
Brand drugs: 202 claims; generic drugs: 258 claims; opioid claims: 25.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ruben W Rhoades $2,321 ($2,321 in general payments such as food, travel and fees) from 3 companies. The largest payer was Genzyme Corporation with $2,300.
| Company | Payments | Amount |
|---|---|---|
| Genzyme Corporation SNY | 1 | $2,300 |
| Octapharma USA, Inc. | 1 | $20.83 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.